- Home
- RFMZ vs TKNO Comparison
RFMZ vs TKNO Comparison
Compare RFMZ & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFMZ
- TKNO
- Stock Information
- Founded
- RFMZ 2021
- TKNO 1996
- Country
- RFMZ United States
- TKNO United States
- Employees
- RFMZ N/A
- TKNO N/A
- Industry
- RFMZ Trusts Except Educational Religious and Charitable
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- RFMZ Finance
- TKNO Health Care
- Exchange
- RFMZ Nasdaq
- TKNO Nasdaq
- Market Cap
- RFMZ 300.5M
- TKNO 356.4M
- IPO Year
- RFMZ N/A
- TKNO 2021
- Fundamental
- Price
- RFMZ $13.09
- TKNO $6.74
- Analyst Decision
- RFMZ
- TKNO Buy
- Analyst Count
- RFMZ 0
- TKNO 1
- Target Price
- RFMZ N/A
- TKNO $5.00
- AVG Volume (30 Days)
- RFMZ 76.6K
- TKNO 437.0K
- Earning Date
- RFMZ 01-01-0001
- TKNO 05-08-2025
- Dividend Yield
- RFMZ 7.43%
- TKNO N/A
- EPS Growth
- RFMZ N/A
- TKNO N/A
- EPS
- RFMZ 0.65
- TKNO N/A
- Revenue
- RFMZ N/A
- TKNO $38,250,000.00
- Revenue This Year
- RFMZ N/A
- TKNO $9.58
- Revenue Next Year
- RFMZ N/A
- TKNO $15.97
- P/E Ratio
- RFMZ $21.49
- TKNO N/A
- Revenue Growth
- RFMZ N/A
- TKNO 3.79
- 52 Week Low
- RFMZ $11.28
- TKNO $1.16
- 52 Week High
- RFMZ $14.57
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- RFMZ 61.24
- TKNO 58.11
- Support Level
- RFMZ $12.85
- TKNO $5.70
- Resistance Level
- RFMZ $13.03
- TKNO $7.48
- Average True Range (ATR)
- RFMZ 0.12
- TKNO 0.51
- MACD
- RFMZ 0.09
- TKNO 0.05
- Stochastic Oscillator
- RFMZ 92.96
- TKNO 58.43
About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.